Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 3284 entries
View as:

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04594642 Org: User:
Start: 03/02/21 End: 04/19/28 Due: 04/19/29

Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population

Phase: N/A Priority: Normal
NCT ID: NCT05966324 Org: User:
Start: 07/05/22 End: 09/20/22 Due: 09/20/23

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05702229 Org: User:
Start: 01/16/23 End: 01/28/27 Due: 01/28/28

A Scintigraphy Study of PT010 in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03906045 Org: User:
Start: 04/04/19 End: 03/05/20 Due: 03/05/21

Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02184195 Org: User:
Start: 12/16/14 End: 01/27/23 Due: 01/27/24

Interaction Between ABT-335, Rosuvastatin and Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT00487136 Org: User:
Start: 06/30/07 End: 07/31/07 Due: 07/31/08

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00255528 Org: User:
Start: 07/31/02 End: - Due: -

A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT03313336 Org: User:
Start: 10/30/17 End: 11/09/17 Due: 11/09/18

ADHERE-S (NIS Brilique)

Phase: N/A Priority: Normal
NCT ID: NCT03444012 Org: User:
Start: 03/05/18 End: 08/13/19 Due: 08/13/20

Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00861718 Org: User:
Start: 04/30/09 End: 10/31/09 Due: 10/31/10

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Phase: N/A Priority: Normal
NCT ID: NCT00558272 Org: User:
Start: 02/29/08 End: 08/31/12 Due: 08/31/13

Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00692289 Org: User:
Start: 06/30/08 End: 07/31/10 Due: 07/31/11

A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01167868 Org: User:
Start: 07/31/10 End: 05/31/11 Due: 05/31/12

Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04200326 Org: User:
Start: 12/20/19 End: 04/09/20 Due: 04/09/21

PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)

Phase: N/A Priority: Normal
NCT ID: NCT03492931 Org: User:
Start: 03/28/18 End: 05/07/19 Due: 05/07/20

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00244634 Org: User:
Start: 09/30/03 End: 11/30/05 Due: 11/30/06

Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

Phase: N/A Priority: Normal
NCT ID: NCT06675552 Org: User:
Start: 11/15/24 End: 12/31/26 Due: 12/31/27

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT06742723 Org: User:
Start: 03/03/25 End: 04/18/30 Due: 04/18/31

SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00272740 Org: User:
Start: 03/31/00 End: - Due: -

CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.

Phase: N/A Priority: Normal
NCT ID: NCT00713960 Org: User:
Start: 04/30/08 End: 12/31/10 Due: 12/31/11

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03333824 Org: User:
Start: 12/01/17 End: 01/22/19 Due: 01/22/20

Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00984477 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10

National Survey on Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00770250 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT01682408 Org: User:
Start: 09/30/12 End: 12/31/12 Due: 12/31/13

A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00703391 Org: User:
Start: 06/30/08 End: 09/30/08 Due: 09/30/09